Related Experiment Video

Updated: Aug 7, 2026

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on: August 18, 2023

Targeted anticancer immunotoxins and cytotoxic agents with direct killing moieties

Koji Kawakami1, Oumi Nakajima, Ryuichi Morishita

  • 1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida Konoecho, Sakyoku, Kyoto 606-8501, Japan. kawakami-k@umin.ac.jp

Thescientificworldjournal
|July 11, 2006
PubMed

Insights

Targeted immunotoxins and cytotoxic agents show promise for cancer therapy by delivering toxins directly to tumor cells. This review covers their development, mechanisms, and future directions for improved cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Bioinformatics advances aid tumor cell characterization but novel cancer vaccines and antibody therapeutics remain challenging.
  • Targeted cancer therapeutics, including immunotoxins and cytotoxic agents, utilize antibodies or ligands fused to toxins for direct tumor cell killing.
  • Two agents, DAB389IL-2 (ONTAKTM) and CD33-calicheamicin (Mylotarg), are FDA-approved for specific leukemias and lymphomas.

Purpose of the Study:

  • To review the generation and development of immunotoxins and cytotoxic agents for cancer therapy.
  • To summarize the mechanisms of action for these targeted cancer therapeutics.
  • To discuss future directions and potential advancements in this therapeutic approach.

Main Methods:

  • Literature review of immunotoxins and cytotoxic agents in cancer therapy.
  • Analysis of approved and investigational agents targeting tumor-specific antigens.
  • Examination of novel technologies like cleavable adapters and immunoliposomes.

Main Results:

  • Several immunotoxins and cytotoxic agents are in clinical trials (e.g., BL22, IL13-PE38QQR).
  • Preclinical development includes agents with innovative delivery systems such as cleavable adapters and immunoliposomes.
  • The development of targeted agents has progressed significantly over the past two decades.

Conclusions:

  • Immunotoxins and cytotoxic agents represent a viable strategy for targeted cancer therapy.
  • Continued research and development are crucial for optimizing efficacy and expanding applications.
  • Future directions may involve novel delivery mechanisms and combination therapies for enhanced outcomes.

More Related Videos

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...